Y
Yaning Li
Researcher at Tsinghua University
Publications - 29
Citations - 5791
Yaning Li is an academic researcher from Tsinghua University. The author has contributed to research in topics: Biology & Coronavirus. The author has an hindex of 8, co-authored 18 publications receiving 3818 citations.
Papers
More filters
Journal ArticleDOI
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies.
Renhong Yan,Ruoke Wang,Bin Ju,Jinfang Yu,Yuanyuan Zhang,Nan Liu,Jia Wang,Qi Zhang,Peng Chen,Bing Zhou,Yaning Li,Yaping Shen,Shuyuan Zhang,Long Tian,Yingying Guo,Lu Xia,Xinyue Zhong,Lin Cheng,Xiangyang Ge,Juanjuan Zhao,Hong-Wei Wang,Xinquan Wang,Zheng Zhang,Linqi Zhang,Qiang Zhou +24 more
TL;DR: In this paper, the bivalent binding of the full-length IgG is found to associate with more RBDs in the "up" conformation than the monovalent binding of Fab, perhaps contributing to the enhanced neutralizing activity of IgG and triggering more shedding of the S1 subunit from the S protein.
Posted ContentDOI
Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis
Fan Wu,Renhong Yan,Liu Mei,Zezhong Liu,Yingdan Wang,Die Luan,Kaiyue Wu,Zhigang Song,Tingting Sun,Yunping Ma,Yuanyuan Zhang,Qimin Wang,Xiang Li,Ping Ji,Yaning Li,Cheng Li,Yanling Wu,Tianlei Ying,Yu-Mei Wen,Shibo Jiang,Tong-Yu Zhu,Lu Lu,Yongzheng Zhang,Qiang Zhou,Jinghe Huang +24 more
TL;DR: Results revealed that ADE mediated by SARS-CoV-2 spike-specific antibodies could result from binding to the receptor in slightly different pattern from antibodies mediating neutralizations, which could be of use for developing novel therapeutic and preventive measures for control of COVID-19 infection.
Journal ArticleDOI
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker.
Yuning Chen,Ya-Nan Zhang,Renhong Yan,Guifeng Wang,Yuanyuan Zhang,Zhe-Rui Zhang,Yaning Li,jianxia ou,Wendi Chu,Zhijuan Liang,yongmei wang,Yi-Li Chen,Ganjun Chen,Qi Wang,Qiang Zhou,Bo Zhang,Bo Zhang,Chunhe Wang +17 more
TL;DR: In this paper, a human angiotensin-converting enzyme 2 (ACE2)-targeting monoclonal antibody, 3E8, blocked the S1-subunits and pseudo-typed virus constructs from multiple coronaviruses including SARS-CoV-2, SARS CoV-1, HCoVNL63, B.1.1, and P.617, without markedly affecting the physiological activities of ACE2 or causing severe toxicity.
Journal ArticleDOI
A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols
Renhong Yan,Pingping Cao,Wenqi Song,Hongwu Qian,Ximing Du,Hudson W. Coates,Xin Zhao,Yaning Li,Shuai Gao,Xin Gong,Ximing Liu,Jianhua Sui,Jianlin Lei,Hongyuan Yang,Andrew J. Brown,Qiang Zhou,Chuangye Yan,Nieng Yan +17 more
TL;DR: In this paper, the sterol regulatory element-binding protein (SREBP) pathway was analyzed in the presence of 25-hydroxycholesterol (25HC)-dependent association of Scap and Insig acts as the master switch for the SREBP pathway.
Posted ContentDOI
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
Renhong Yan,Ruoke Wang,Bin Ju,Jinfang Yu,Yuanyuan Zhang,Nan Liu,Jia Wang,Qi Zhang,Peng Chen,Bing Zhou,Yaning Li,Shuyuan Zhang,Long Tian,Xinyue Zhong,Lin Cheng,Xiangyang Ge,Juanjuan Zhao,Hong-Wei Wang,Xinquan Wang,Zheng Zhang,Linqi Zhang,Qiang Zhou +21 more
TL;DR: Cryo-EM structures of the ten most potent nAbs in their native full-length IgG or Fab forms bound to the trimeric S protein of SARS-CoV-2 reveal the bivalent binding and their correlation with more potent neutralization and the shedding of S1 subunit.